FDA scientists opposed Trump administration’s move to ease peptide access
Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientistsA plan to give people in the United States easier access to unproven peptide drugs favored by the US health secretary, Robert F Kennedy Jr, was opposed by most Food and Drug Administration scientific staff members, who had limited input in drafting the policy, according to six people…
Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientistsA plan to give people in the United States easier access to unproven peptide drugs favored by the US health secretary, Robert F Kennedy Jr, was opposed by most Food and Drug Administration scientific staff members, who had limited input in drafting the policy, according to six people…
Source: The Guardian World — Original report ↗
WorldLine News is displaying a source-attributed brief. Details may evolve. The linked publication is responsible for its original reporting.